Trial intelligence / Profile preview

Efficacy of Stannous Fluoride Toothpaste for Dentin Hypersensitivity

NCT06359028Completed

Sponsor
Haleon
Start
Mar 2024
Primary completion
Jun 2024
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised, single-blind trial of stannous fluoride in dentin hypersensitivity (DH) (2 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56. Started Mar 2024; status: completed.

02

Drugs

stannous fluoride
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT06359028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06359028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call